Nano Safe Coatings, LLC is a US based Biotech company leading in antimicrobial surface protection. Nano Safe has developed proprietary thermal, UV and hybrid cure antimicrobial formulations that covalently bond to surfaces and create a uniform polymeric-coating for lasting antimicrobial protection.
Nano Safe utilizes modified organofunctional silane antimicrobial technology to create an invisible, non-toxic antimicrobial coating to effectively lyse or disintegrate the microbe’s cell membrane, preventing the attachment of microorganisms and subsequent growth of biofilms.
Since bacteria and fungi are ubiquitous, even with judicious cleaning, packaging and use protocols, microbes can find their way to devices ex-vivo and in-vivo. Prevention of microbial attachment and biofilm development can help in addressing the challenges with device-related infection and its impact on device performance and outcomes.
Nano Safe Coatings has conducted extensive work into the molecular design, efficacy and biocompatibility testing to best understand and inform the application of its technologies on medical devices. Nano Safe Coatings holds patent registrations on its technologies in several countries around the world.
NSC and AMC have created a strategic alliance to best serve the medical device industry. AMC has over 25 years of precision coating of medical devices. From proof of concept to large scale coating production, AMC consistently delivers on the highest quality manufacturer standards. Nano Safe Coatings is proud bring its antimicrobial technologies to AMC and their customers and to have AMC’s collaboration and experience to help in optimizing NSC’s antimicrobial coatings to provide world class solutions in the medical device industry.
[1] As demonstrated through extensive internal development and testing and as part of the information included in Nano Safe Coating’s FDA Device Master File.
[2] Device-Related Infections. Racing for the Surface. (2020) (https://doi.org/10.1007/978-3-030-34475-7_7)
[3] Implantable Device Related Infection, Shock (2016) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110396/)
[4] Persistence of SARS-CoV-2 infection on personal protective equipment (PPE), BMC Infectious disease (2021) (https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06861-7)
[5] Hospital-Acquired Infections Under Pay-for-Performance Systems: an Administrative Perspective on Management and Change. Vokes, R.A., Bearman, G. & Bazzoli, G.J., Curr Infect Dis Rep 20, 35 (2018). (https://doi.org/10.1007/
[6] Lukas Porosa, Alexander Caschera, Joseph Bedard, Amanda Mocella, Evan Ronan, Alan J. Lough, Gideon Wolfaardt, and Daniel A. Foucher, UV-Curable Contact Active Benzophenone Terminated Quaternary Ammonium Antimicrobials for Applications in Polymer Plastics and Related Devices, ACS Applied Materials & Interfaces 2017 9 (33), 27491-27503